These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
295 related articles for article (PubMed ID: 26325263)
1. Influence of malaria transmission intensity and the 581G mutation on the efficacy of intermittent preventive treatment in pregnancy: systematic review and meta-analysis. Chico RM; Cano J; Ariti C; Collier TJ; Chandramohan D; Roper C; Greenwood B Trop Med Int Health; 2015 Dec; 20(12):1621-33. PubMed ID: 26325263 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of sulphadoxine-pyrimethamine for intermittent preventive treatment of malaria in pregnancy: a retrospective birth outcomes study in Mansa, Zambia. Mace KE; Chalwe V; Katalenich BL; Nambozi M; Mubikayi L; Mulele CK; Wiegand RE; Filler SJ; Kamuliwo M; Craig AS; Tan KR Malar J; 2015 Feb; 14():69. PubMed ID: 25890159 [TBL] [Abstract][Full Text] [Related]
3. Effect of Plasmodium falciparum sulfadoxine-pyrimethamine resistance on the effectiveness of intermittent preventive therapy for malaria in pregnancy in Africa: a systematic review and meta-analysis. van Eijk AM; Larsen DA; Kayentao K; Koshy G; Slaughter DEC; Roper C; Okell LC; Desai M; Gutman J; Khairallah C; Rogerson SJ; Hopkins Sibley C; Meshnick SR; Taylor SM; Ter Kuile FO Lancet Infect Dis; 2019 May; 19(5):546-556. PubMed ID: 30922818 [TBL] [Abstract][Full Text] [Related]
4. Lack of effect of intermittent preventive treatment for malaria in pregnancy and intense drug resistance in western Uganda. Braun V; Rempis E; Schnack A; Decker S; Rubaihayo J; Tumwesigye NM; Theuring S; Harms G; Busingye P; Mockenhaupt FP Malar J; 2015 Sep; 14():372. PubMed ID: 26410081 [TBL] [Abstract][Full Text] [Related]
5. Decrease of microscopic Plasmodium falciparum infection prevalence during pregnancy following IPTp-SP implementation in urban cities of Gabon. Bouyou-Akotet MK; Mawili-Mboumba DP; Kendjo E; Moutandou Chiesa S; Tshibola Mbuyi ML; Tsoumbou-Bakana G; Zong J; Ambounda N; Kombila M Trans R Soc Trop Med Hyg; 2016 Jun; 110(6):333-42. PubMed ID: 27268713 [TBL] [Abstract][Full Text] [Related]
6. Individual efficacy of intermittent preventive treatment with sulfadoxine-pyrimethamine in primi- and secundigravidae in rural Burkina Faso: impact on parasitaemia, anaemia and birth weight. Gies S; Coulibaly SO; Ouattara FT; D'Alessandro U Trop Med Int Health; 2009 Feb; 14(2):174-82. PubMed ID: 19171009 [TBL] [Abstract][Full Text] [Related]
7. Intermittent preventive treatment of malaria with sulphadoxine-pyrimethamine during pregnancy in Burkina Faso: effect of adding a third dose to the standard two-dose regimen on low birth weight, anaemia and pregnancy outcomes. Valea I; Tinto H; Drabo MK; Huybregts L; Henry MC; Roberfroid D; Guiguemde RT; Kolsteren P; D'Alessandro U; Malar J; 2010 Nov; 9():324. PubMed ID: 24576068 [TBL] [Abstract][Full Text] [Related]
8. Estimated impact on birth weight of scaling up intermittent preventive treatment of malaria in pregnancy given sulphadoxine-pyrimethamine resistance in Africa: A mathematical model. Walker PG; Floyd J; Ter Kuile F; Cairns M PLoS Med; 2017 Feb; 14(2):e1002243. PubMed ID: 28245259 [TBL] [Abstract][Full Text] [Related]
9. Occurrence of septuple and elevated Pfdhfr-Pfdhps quintuple mutations in a general population threatens the use of sulfadoxine-pyrimethamine for malaria prevention during pregnancy in eastern-coast of Tanzania. Bwire GM; Mikomangwa WP; Kilonzi M BMC Infect Dis; 2020 Jul; 20(1):530. PubMed ID: 32698764 [TBL] [Abstract][Full Text] [Related]
10. An evaluation of the effects of intermittent sulfadoxine-pyrimethamine treatment in pregnancy on parasite clearance and risk of low birthweight in rural Malawi. Verhoeff FH; Brabin BJ; Chimsuku L; Kazembe P; Russell WB; Broadhead RL Ann Trop Med Parasitol; 1998 Mar; 92(2):141-50. PubMed ID: 9625909 [TBL] [Abstract][Full Text] [Related]
11. Impact of Sulfadoxine-Pyrimethamine Resistance on Effectiveness of Intermittent Preventive Therapy for Malaria in Pregnancy at Clearing Infections and Preventing Low Birth Weight. Desai M; Gutman J; Taylor SM; Wiegand RE; Khairallah C; Kayentao K; Ouma P; Coulibaly SO; Kalilani L; Mace KE; Arinaitwe E; Mathanga DP; Doumbo O; Otieno K; Edgar D; Chaluluka E; Kamuliwo M; Ades V; Skarbinski J; Shi YP; Magnussen P; Meshnick S; Ter Kuile FO Clin Infect Dis; 2016 Feb; 62(3):323-333. PubMed ID: 26486699 [TBL] [Abstract][Full Text] [Related]
12. Intermittent screening and treatment with artemether-lumefantrine versus intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in pregnancy: a facility-based, open-label, non-inferiority trial in Nigeria. Esu E; Berens-Riha N; Pritsch M; Nwachuku N; Loescher T; Meremikwu M Malar J; 2018 Jul; 17(1):251. PubMed ID: 29976228 [TBL] [Abstract][Full Text] [Related]
13. Decline of placental malaria in southern Ghana after the implementation of intermittent preventive treatment in pregnancy. Hommerich L; von Oertzen C; Bedu-Addo G; Holmberg V; Acquah PA; Eggelte TA; Bienzle U; Mockenhaupt FP Malar J; 2007 Nov; 6():144. PubMed ID: 17996048 [TBL] [Abstract][Full Text] [Related]
14. Adverse birth outcomes among mothers who received intermittent preventive treatment with Sulphadoxine-Pyrimethamine in the low malaria transmission region. Mikomangwa WP; Oms M; Aklillu E; Kamuhabwa AAR BMC Pregnancy Childbirth; 2019 Jul; 19(1):236. PubMed ID: 31286878 [TBL] [Abstract][Full Text] [Related]
15. A randomized, placebo-controlled trial of intermittent preventive treatment with sulphadoxine-pyrimethamine in Gambian multigravidae. Mbaye A; Richardson K; Balajo B; Dunyo S; Shulman C; Milligan P; Greenwood B; Walraven G Trop Med Int Health; 2006 Jul; 11(7):992-1002. PubMed ID: 16827700 [TBL] [Abstract][Full Text] [Related]
16. Safety and toxicity of sulfadoxine/pyrimethamine: implications for malaria prevention in pregnancy using intermittent preventive treatment. Peters PJ; Thigpen MC; Parise ME; Newman RD Drug Saf; 2007; 30(6):481-501. PubMed ID: 17536875 [TBL] [Abstract][Full Text] [Related]
17. Intermittent preventive treatment with Sulphadoxine-Pyrimethamine (IPTp-SP) is associated with protection against sub-microscopic P. falciparum infection in pregnant women during the low transmission dry season in southwestern Cameroon: A Semi - longitudinal study. Apinjoh TO; Ntui VN; Chi HF; Moyeh MN; Toussi CT; Mayaba JM; Tangi LN; Kwi PN; Anchang-Kimbi JK; Dionne-Odom J; Tita ATN; Achidi EA; Amambua-Ngwa A; Titanji VPK PLoS One; 2022; 17(9):e0275370. PubMed ID: 36178962 [TBL] [Abstract][Full Text] [Related]
18. Interactions Between Antenatal Sulfadoxine-Pyrimethamine, Drug-Resistant Plasmodium falciparum Parasites, and Delivery Outcomes in Malawi. Taylor SM; Levitt B; Freedman B; Madanitsa M; Thwai KL; Kalilani-Phiri L; Khairallah C; Mwapasa V; Ter Kuile FO; Meshnick SR J Infect Dis; 2020 Jul; 222(4):661-669. PubMed ID: 32221555 [TBL] [Abstract][Full Text] [Related]
19. In vivo efficacy of sulphadoxine-pyrimethamine for the treatment of asymptomatic parasitaemia in pregnant women in Machinga District, Malawi. Gutman J; Mwandama D; Wiegand RE; Abdallah J; Iriemenam NC; Shi YP; Mathanga DP; Skarbinski J Malar J; 2015 May; 14():197. PubMed ID: 25962439 [TBL] [Abstract][Full Text] [Related]
20. Impact on pregnancy outcomes of intermittent preventive treatment with sulfadoxine-pyrimethamine in urban and peri-urban Papua New Guinea: a retrospective cohort study. Cellich P; Unger HW; Rogerson SJ; Mola GDL Malar J; 2024 Jul; 23(1):201. PubMed ID: 38970076 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]